Order Article Reprints

Colpani A, De Vito A, Marino A, Ceccarelli M, Celesia BM, Conti GN, Spampinato S, Moi G, Venanzi Rullo E, Pellicanò GF, et al. Viro-Immunological Efficacy and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide among Women Living with HIV: A 96-Week Post-Switch Analysis from the Real-Life SHiNe-SHiC Cohort. Biomedicines. 2024; 12(10):2311. https://doi.org/10.3390/biomedicines12102311

Colpani, Agnese, Andrea De Vito, Andrea Marino, Manuela Ceccarelli, Benedetto Maurizio Celesia, Giuseppe Nicolò Conti, Serena Spampinato, Giulia Moi, Emmanuele Venanzi Rullo, Giovanni Francesco Pellicanò, and et al. 2024. "Viro-Immunological Efficacy and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide among Women Living with HIV: A 96-Week Post-Switch Analysis from the Real-Life SHiNe-SHiC Cohort" Biomedicines 12, no. 10: 2311. https://doi.org/10.3390/biomedicines12102311

Colpani, A., De Vito, A., Marino, A., Ceccarelli, M., Celesia, B. M., Conti, G. N., Spampinato, S., Moi, G., Venanzi Rullo, E., Pellicanò, G. F., Sofia, S. A., Pantò, G., Iacobello, C., Frasca, C. M., Montineri, A., Albanese, A., Angioni, G., Cacopardo, B., Madeddu, G., ... on behalf of Sardinian HIV Network and Sicilian HIV Cohort (SHiNe-SHiC) Research Group. (2024). Viro-Immunological Efficacy and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide among Women Living with HIV: A 96-Week Post-Switch Analysis from the Real-Life SHiNe-SHiC Cohort. Biomedicines, 12(10), 2311. https://doi.org/10.3390/biomedicines12102311